Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CAMDEN CLARK MEMORIAL HOSPITAL CORPORATION

NPI: 1699704254 · PARKERSBURG, WV 26101 · General Acute Care Hospital · NPI assigned 07/03/2006

$56.26M
Total Medicaid Paid
1,374,029
Total Claims
1,111,248
Beneficiaries
481
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPIERSON, KYLE (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date07/03/2006

Related Entities

Other providers sharing the same authorized official: PIERSON, KYLE

ProviderCityStateTotal Paid
CAMDEN CLARK MEMORIAL HOSPITAL CORPORATION PARKERSBURG WV $5.25M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 207,177 $14.52M
2019 142,473 $9.86M
2020 240,830 $15.83M
2021 225,818 $5.01M
2022 139,606 $2.78M
2023 221,983 $4.19M
2024 196,142 $4.07M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 17,997 15,243 $6.40M
99284 Emergency department visit for the evaluation and management, high severity 31,077 26,849 $5.24M
99283 Emergency department visit for the evaluation and management, moderate severity 29,766 26,377 $3.12M
74177 Computed tomography, abdomen and pelvis; with contrast material 7,389 6,520 $2.00M
80053 Comprehensive metabolic panel 83,523 67,418 $1.46M
41899 Unlisted procedure, dentoalveolar structures 1,039 819 $1.40M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 83,208 63,575 $1.19M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 4,472 4,138 $996K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2,377 2,143 $854K
70450 Computed tomography, head or brain; without contrast material 8,922 7,902 $852K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 14,440 9,601 $788K
96375 Therapeutic injection; each additional sequential IV push 19,605 14,277 $715K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4,812 4,444 $697K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 18,483 15,291 $674K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,284 2,910 $639K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 38,298 30,856 $622K
99282 Emergency department visit for the evaluation and management, low to moderate severity 8,237 7,313 $574K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 11,081 9,239 $532K
G0378 Hospital observation service, per hour 11,422 4,134 $521K
71275 Computed tomographic angiography, chest, with contrast material 1,955 1,740 $519K
84484 23,967 16,554 $480K
84443 Thyroid stimulating hormone (TSH) 19,916 18,325 $472K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 5,582 4,754 $463K
71046 Radiologic examination, chest; 2 views 14,869 13,524 $449K
0099U 1,033 886 $435K
96376 6,530 3,449 $432K
81001 29,017 24,636 $427K
85027 24,713 20,423 $419K
J2405 Injection, ondansetron hydrochloride, per 1 mg 18,069 13,604 $419K
71260 Computed tomography, thorax, diagnostic; with contrast material 2,322 2,127 $415K
81025 13,437 11,314 $404K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 4,123 2,344 $391K
71045 Radiologic examination, chest; single view 19,213 16,343 $385K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 2,405 2,172 $375K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13,503 8,627 $365K
J7120 Ringers lactate infusion, up to 1000 cc 10,475 8,592 $357K
88305 Level IV - Surgical pathology, gross and microscopic examination 6,193 5,503 $334K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 11,930 10,339 $332K
93017 2,981 2,710 $330K
87086 Culture, bacterial; quantitative colony count, urine 19,405 16,845 $326K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 7,117 6,619 $318K
77067 Screening mammography, bilateral, including computer-aided detection 3,533 3,270 $305K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 4,159 3,859 $300K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 3,321 1,785 $300K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5,625 5,075 $293K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5,608 5,061 $287K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 747 690 $281K
80048 Basic metabolic panel (calcium, ionized) 18,448 14,110 $274K
96361 Intravenous infusion, hydration; each additional hour 7,541 5,806 $269K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 7,710 5,780 $269K
36415 Collection of venous blood by venipuncture 50,041 37,224 $266K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 14,449 13,081 $264K
83735 18,135 10,930 $259K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 6,150 5,051 $255K
80061 Lipid panel 13,036 12,333 $251K
83690 13,371 11,370 $251K
J2250 Injection, midazolam hydrochloride, per 1 mg 8,108 6,933 $243K
64493 180 107 $241K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,796 2,511 $239K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 16,697 13,236 $236K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,329 7,250 $235K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 6,798 3,831 $232K
85610 22,145 18,290 $230K
72125 Computed tomography, cervical spine; without contrast material 2,954 2,679 $230K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,678 2,438 $222K
J2785 Injection, regadenoson, 0.1 mg 1,561 1,392 $202K
85730 18,326 15,450 $201K
81003 15,826 14,226 $188K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 522 495 $171K
74178 423 402 $167K
87522 Neg quan hep c or qual rna 2,418 2,257 $163K
82150 3,308 2,786 $162K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 10,217 9,109 $162K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 5,048 2,751 $158K
83880 4,665 4,042 $155K
93880 2,536 2,385 $153K
87040 7,416 4,691 $152K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 5,133 4,842 $150K
74018 4,479 3,925 $142K
71250 1,537 1,459 $141K
80305 3,731 3,225 $136K
87631 818 728 $134K
96367 3,484 2,245 $133K
87186 8,158 7,165 $131K
72110 2,717 2,554 $130K
83605 7,795 6,217 $129K
80074 2,419 2,238 $129K
86850 5,835 5,089 $125K
88142 4,078 3,716 $125K
84439 5,820 5,432 $125K
83721 7,009 6,176 $123K
83036 Hemoglobin; glycosylated (A1C) 10,302 9,651 $123K
78815 Positron emission tomography (PET) for limited area imaging 279 256 $122K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,385 3,443 $121K
84702 4,259 3,392 $121K
J2270 Injection, morphine sulfate, up to 10 mg 6,196 4,192 $120K
85007 4,504 3,340 $115K
86900 5,604 4,879 $110K
76536 1,176 1,122 $108K
0202U Oncology (prostate), multianalyte, gene expression profiling 2,959 2,686 $108K
86140 9,113 7,545 $105K
87070 6,601 5,892 $100K
86901 5,596 4,873 $99K
93971 1,742 1,590 $97K
87088 6,102 5,439 $95K
76770 1,087 1,011 $94K
70486 643 612 $91K
95810 Polysomnography; sleep staging with 4 or more additional parameters 137 121 $88K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 270 244 $87K
J2175 Injection, meperidine hydrochloride, per 100 mg 836 634 $84K
72141 140 134 $84K
82803 3,023 2,322 $84K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,752 1,540 $81K
93970 888 814 $81K
86803 3,517 3,308 $77K
72050 1,216 1,150 $76K
88304 762 666 $74K
82607 3,855 3,606 $74K
73630 2,778 2,397 $73K
76642 1,343 1,132 $73K
82565 3,538 2,335 $70K
36600 2,550 2,024 $70K
85379 2,885 2,524 $69K
73030 2,565 2,251 $68K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 421 375 $64K
74022 833 749 $64K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 678 612 $64K
64494 118 74 $64K
73130 1,791 1,544 $63K
87486 664 598 $63K
87581 662 596 $63K
62323 237 210 $63K
85651 5,493 4,683 $62K
84145 2,229 1,848 $59K
77063 Screening digital breast tomosynthesis, bilateral 2,440 2,303 $58K
84520 2,421 1,545 $56K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 261 240 $56K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,706 3,975 $56K
73610 1,676 1,500 $55K
78227 187 183 $55K
84100 5,256 3,322 $55K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 446 393 $54K
82728 3,793 3,517 $53K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 718 641 $52K
87077 3,168 2,758 $52K
J0690 Injection, cefazolin sodium, 500 mg 1,598 1,128 $52K
J1650 Injection, enoxaparin sodium, 10 mg 4,559 2,004 $51K
80051 1,275 712 $51K
94060 1,928 1,833 $51K
86756 655 582 $50K
85018 2,592 2,274 $49K
87902 223 197 $48K
84481 1,410 1,336 $48K
84460 1,727 1,065 $48K
70491 130 115 $48K
97161 2,013 1,715 $47K
87276 1,099 957 $46K
84450 1,607 973 $46K
87275 1,101 959 $46K
82247 2,555 1,330 $45K
82248 5,305 4,398 $45K
94726 1,787 1,702 $45K
87340 2,740 2,558 $44K
88342 1,032 925 $44K
J1644 Injection, heparin sodium, per 1000 units 3,867 1,540 $43K
93458 14 12 $43K
70551 Magnetic resonance imaging, brain; without contrast material 93 85 $42K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 378 351 $42K
94729 1,993 1,892 $41K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,189 1,810 $39K
87075 2,519 2,170 $39K
84075 1,355 754 $39K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2,835 2,553 $39K
76830 Ultrasound, transvaginal 430 389 $38K
73562 1,105 901 $38K
86592 3,831 3,564 $37K
83655 1,663 1,585 $37K
73564 970 854 $37K
78226 189 167 $36K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml 1,323 1,212 $36K
73110 878 799 $36K
J2765 Injection, metoclopramide hcl, up to 10 mg 2,304 1,705 $36K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,279 1,186 $35K
90715 1,060 969 $34K
87205 3,530 3,094 $34K
74420 185 145 $32K
99281 Emergency department visit for the evaluation and management, self-limited or minor 639 587 $32K
72100 784 730 $31K
87081 1,560 1,439 $31K
97165 1,355 1,171 $31K
36000 354 334 $30K
83970 1,037 975 $30K
72131 212 197 $29K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,745 1,654 $29K
87147 1,315 1,193 $28K
J3475 Injection, magnesium sulfate, per 500 mg 2,103 1,481 $28K
83540 3,519 3,282 $28K
80050 General health panel 695 657 $27K
73560 892 739 $27K
82746 1,473 1,376 $27K
G0475 Hiv antigen/antibody, combination assay, screening 1,986 1,862 $25K
82043 2,964 2,808 $25K
72040 531 502 $25K
82553 620 562 $25K
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,101 1,586 $25K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 325 300 $24K
82570 3,347 3,107 $24K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,627 1,405 $24K
76700 Ultrasound, abdominal, real time with image documentation; complete 306 295 $24K
84153 1,142 1,085 $24K
86762 1,122 1,056 $24K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,111 1,056 $23K
J2060 Injection, lorazepam, 2 mg 1,451 1,096 $23K
86038 984 927 $23K
83516 995 706 $23K
73502 1,101 1,042 $22K
88720 3,426 1,975 $22K
77065 Tomosynthesis, mammo 384 358 $22K
84403 506 475 $22K
97602 350 231 $21K
84436 466 434 $21K
59025 Fetal non-stress test 266 221 $21K
J2370 Injection, phenylephrine hcl, up to 1 ml 84 71 $20K
72072 395 376 $19K
86003 59 39 $19K
J2360 Injection, orphenadrine citrate, up to 60 mg 415 369 $18K
81596 247 227 $18K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1,482 1,442 $18K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 856 754 $17K
86480 213 202 $17K
Q9957 Injection, perflutren lipid microspheres, per ml 340 298 $17K
93296 1,472 1,375 $16K
86677 482 456 $16K
12001 234 224 $16K
84146 442 406 $16K
74246 281 260 $16K
J3370 Injection, vancomycin hcl, 500 mg 1,517 687 $15K
86703 480 438 $15K
84112 174 147 $14K
82550 1,359 976 $14K
73080 455 419 $14K
73590 399 340 $13K
45380 Colonoscopy, flexible; with biopsy, single or multiple 46 44 $13K
84132 224 173 $13K
J2805 Injection, sincalide, 5 micrograms 184 181 $13K
73221 27 24 $13K
86706 680 607 $13K
94618 410 380 $13K
84550 1,938 1,711 $12K
88185 142 127 $12K
82950 971 913 $12K
84402 191 181 $12K
70498 413 370 $12K
96523 407 281 $12K
70496 287 257 $11K
84466 2,066 1,933 $11K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 345 185 $11K
86431 714 676 $11K
82947 951 872 $11K
86200 392 363 $10K
82962 7,546 3,695 $10K
80076 659 574 $10K
96415 353 239 $10K
83525 432 400 $9K
J1956 Injection, levofloxacin, 250 mg 16 12 $9K
95819 45 43 $9K
Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml 185 157 $9K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 54 38 $9K
84156 1,408 1,271 $9K
G0379 Direct admission of patient for hospital observation care 86 73 $9K
86696 359 341 $9K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 134 131 $9K
97597 152 91 $9K
J7060 5% dextrose/water (500 ml = 1 unit) 272 109 $9K
86376 163 158 $8K
J2704 Injection, propofol, 10 mg 6,348 5,682 $8K
82010 247 194 $7K
86790 595 542 $7K
77336 178 70 $7K
76870 82 77 $7K
86695 359 341 $7K
J1030 Injection, methylprednisolone acetate, 40 mg 775 663 $7K
J2469 Injection, palonosetron hcl, 25 mcg 216 125 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 193 175 $6K
93924 69 67 $6K
86308 58 55 $6K
72170 390 355 $6K
86255 225 206 $6K
80143 603 536 $6K
96417 145 102 $6K
96368 165 111 $6K
86704 187 184 $6K
97116 645 362 $6K
64635 43 31 $6K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 102 92 $6K
93325 119 107 $6K
78306 26 25 $6K
73120 216 141 $6K
88184 141 127 $6K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 165 146 $6K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 73 58 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 12 12 $5K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 132 125 $5K
73090 181 164 $5K
90686 356 334 $5K
87324 191 173 $5K
94664 113 93 $5K
10060 81 70 $5K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,303 1,197 $5K
80055 136 128 $5K
82785 60 57 $5K
Q3014 Telehealth originating site facility fee 540 508 $5K
82310 391 270 $5K
83615 848 685 $5K
87427 193 174 $5K
93923 159 153 $4K
87045 230 211 $4K
74230 89 82 $4K
90472 Immunization administration, each additional vaccine (list separately) 235 211 $4K
92611 87 82 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 60 41 $4K
87046 230 211 $4K
88307 33 32 $4K
J0694 Injection, cefoxitin sodium, 1 gm 25 16 $4K
97530 Therapeutic activities, direct patient contact, each 15 minutes 617 268 $4K
83001 137 123 $3K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 25 25 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 29 26 $3K
93308 96 90 $3K
73552 91 80 $3K
76882 33 29 $3K
86235 74 58 $3K
J0692 Injection, cefepime hydrochloride, 500 mg 504 273 $3K
A9561 Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries 41 39 $3K
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 89 55 $3K
82140 214 182 $3K
J1815 Injection, insulin, per 5 units 645 461 $3K
86618 180 97 $3K
87210 58 51 $3K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 74 73 $3K
71101 109 105 $2K
J3105 Injection, terbutaline sulfate, up to 1 mg 49 40 $2K
58563 14 13 $2K
74240 52 51 $2K
64451 17 15 $2K
86694 26 25 $2K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,568 1,091 $2K
82533 83 70 $2K
86780 239 214 $2K
94010 62 59 $2K
80069 206 187 $2K
86905 28 26 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 40 40 $2K
95806 53 52 $2K
87209 49 47 $2K
74019 131 129 $2K
81513 16 14 $2K
73522 32 31 $2K
99495 186 176 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 543 472 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 30 29 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 136 125 $1K
96110 Developmental screening, with scoring and documentation, per standardized instrument 130 130 $1K
J3411 Injection, thiamine hcl, 100 mg 18 15 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 12 12 $1K
93242 95 84 $1K
29125 15 13 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 49 47 $1K
77334 24 14 $1K
93320 12 12 $1K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 45 40 $1K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 53 50 $1K
83002 77 63 $1K
86709 36 35 $1K
82977 41 33 $1K
93280 132 117 $1K
87177 49 47 $1K
J0780 Injection, prochlorperazine, up to 10 mg 92 72 $1K
77300 14 12 $1K
93299 61 56 $1K
83013 17 16 $1K
73620 44 41 $984.33
85576 33 30 $952.19
80081 14 14 $943.18
86708 28 27 $926.70
85045 62 56 $914.50
82105 98 95 $910.05
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 50 49 $897.91
87481 30 26 $894.16
85046 245 220 $847.97
86160 47 43 $784.15
36569 16 12 $784.00
93922 44 41 $764.01
86364 103 94 $746.07
J3490 Unclassified drugs 8,341 2,672 $729.80
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 17 17 $715.12
36416 451 238 $663.42
90656 193 188 $617.59
12002 13 12 $602.50
J1170 Injection, hydromorphone, up to 4 mg 744 564 $601.09
80164 45 41 $583.53
87641 25 24 $583.51
86800 15 13 $560.31
11721 177 174 $548.67
J3010 Injection, fentanyl citrate, 0.1 mg 2,831 2,407 $530.83
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 55 30 $515.75
73060 42 41 $495.59
82365 16 14 $482.82
77061 159 152 $465.97
77080 26 25 $451.57
J0701 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg 67 42 $441.81
88300 13 12 $433.18
81511 18 14 $403.39
72202 26 24 $400.42
64636 20 12 $395.88
84479 40 39 $370.69
71271 14 13 $367.74
93799 100 88 $354.90
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 14 14 $331.45
82670 15 14 $328.32
95250 12 12 $322.17
96127 103 98 $315.89
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 1,043 624 $308.34
86147 14 12 $302.45
74220 13 12 $276.45
86705 30 25 $267.58
82784 40 24 $259.73
J3480 Injection, potassium chloride, per 2 meq 309 207 $254.01
93882 17 17 $251.69
84270 14 13 $246.65
J1940 Injection, furosemide, up to 20 mg 130 90 $237.94
90694 100 99 $232.50
J2919 Injection, methylprednisolone sodium succinate, 5 mg 156 111 $205.46
76857 17 17 $199.60
51798 171 160 $195.49
93298 49 49 $188.38
83520 14 14 $179.29
82272 46 39 $162.53
J1040 Injection, methylprednisolone acetate, 80 mg 47 38 $144.27
J1630 Injection, haloperidol, up to 5 mg 65 55 $133.09
70250 12 12 $131.46
36592 14 12 $129.14
73521 13 13 $115.97
92610 16 13 $102.99
82085 12 12 $102.24
81002 60 53 $95.06
90474 12 12 $94.90
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 628 444 $92.83
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 173 141 $89.08
90653 38 38 $83.49
J1010 Injection, methylprednisolone acetate, 1 mg 163 157 $83.07
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 14 14 $82.44
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 271 226 $78.65
C1755 Catheter, intraspinal 35 25 $76.53
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 230 205 $70.88
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 960 688 $59.34
A4648 Tissue marker, implantable, any type, each 286 265 $56.71
97535 Self-care/home management training, each 15 minutes 79 53 $31.31
A9573 Injection, gadopiclenol, 1 ml 189 185 $25.76
93321 15 14 $23.84
C9113 Injection, pantoprazole sodium, per vial 606 333 $23.37
80349 200 177 $15.89
J2470 Injection, pantoprazole sodium, 40 mg 23 17 $12.99
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 42 38 $12.03
C1769 Guide wire 266 180 $1.09
S5553 Insulin, long acting; 5 units 17 12 $0.60
J1171 Injection, hydromorphone, 0.1 mg 78 50 $0.45
90671 45 44 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 76 67 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 118 78 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 75 68 $0.00
C1758 Catheter, ureteral 15 12 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 15 12 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 29 26 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 15 12 $0.00
94070 14 13 $0.00
80324 60 54 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 211 187 $0.00
G0008 Administration of influenza virus vaccine 14 14 $0.00
J7674 Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg 14 13 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 13 12 $0.00